Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
What is Becton Dickinson and Co (BDX)'s P/E Ratio?
The P/E ratio of Becton Dickinson and Co is 24.196
Who is the CEO of Becton Dickinson and Co?
Mr. Thomas Polen is the Chairman of the Board of Becton Dickinson and Co, joining the firm since 2014.
What is the price performance of BDX stock?
The current price of BDX is $142.56, it has increased 1.31% in the last trading day.
What are the primary business themes or industries for Becton Dickinson and Co?
Becton Dickinson and Co belongs to Health Care industry and the sector is Health Care
What is Becton Dickinson and Co market cap?
Becton Dickinson and Co's current market cap is $39.2B
Is Becton Dickinson and Co a buy, sell, or hold?
According to wall street analysts, 16 analysts have made analyst ratings for Becton Dickinson and Co, including 4 strong buy, 3 buy, 11 hold, 0 sell, and 4 strong sell